Literature DB >> 32514566

Does an association exist between menstrual cycle length within the normal range and ovarian reserve biomarkers during the reproductive years? A systematic review and meta-analysis.

Johnny S Younis1,2, Rula Iskander1, Bart C J M Fauser3, Ido Izhaki4.   

Abstract

BACKGROUND: Regular menstrual cycling during the reproductive years is an indicator of spontaneous ovulation but sometimes falsely perceived as an indicator of preserved fertility. In contrast, menstrual cycle shortening, a physiologic occurrence preceding the menopausal transition, is not usually perceived as an indicator of decreased ovarian reserve in the general population. OBJECTIVE AND RATIONALE: The individual decrease in menstrual cycle length (MCL) might represent a sensitive biomarker of diminishing ovarian reserve. The aim of this systematic review and meta-analysis is to examine the possible association between MCL in regularly cycling women (21-35 days) and ovarian reserve tests (ORT), fecundability in natural cycles and IVF outcomes. SEARCH
METHODS: An electronic database search employing PubMed, Web of Science, Trip, EBSCO, ClinicalTrials.gov and the Cochrane library was performed to identify research articles, only on human, published between January 1978 and August 2019. Search terms were pregnancy OR fertility OR fecundity OR fecundability, anti-Müllerian hormone OR AMH OR antral follicle count OR AFC OR ovarian reserve OR ovarian reserve test, in vitro fertilization OR ART OR assisted reproductive therapy OR assisted reproductive treatment OR assisted reproductive technology OR IVF OR ICSI, menstrual cycle length OR menstrual cycle characteristics. We combined these terms to complete the search. All prospective and retrospective studies exploring an association between MCL and proxies of ovarian reserve were included. The exclusions included studies of PCOS, ovarian failure, oral contraception treatment, prior chemotherapy and/or radiotherapy or ovarian surgery. The Newcastle-Ottawa scale was used to assess the quality of studies that were eligible for meta-analysis. OUTCOMES: Eleven studies were eligible for meta-analysis, including 12 031 women. The included studies had a low risk of bias. Short MCL (21-27 days) was associated with lower ORT values as compared to normal (28-31 days), long (32-35 days) and all other (28-35 days) MCL sets. The estimated weighted mean difference (WMD) of AMH level was -1.3 ng/mL (95% CI: -1.75 to -0.86, P < 0.001) between the short and normal MCL sets. The estimated WMD of AFC values was -5.17 (95% CI: -5.96 to -4.37, P < 0.001) between the short and normal MCL sets. The weighted overall odds ratio (OR) of fecundability in natural cycles between women with short versus normal MCL sets was statistically significant (overall OR 0.81; 95% CI 0.72-0.91, P < 0.001). In the IVF setting, fewer oocytes were retrieved in short MCL in comparison to normal, long and all other MCL sets, with an estimated WMD of -1.8 oocytes (95% CI: -2.5 to -1.1, P < 0.001) in the short versus normal MCL sets. The weighted overall OR of clinical pregnancy rate between women with short versus all other MCL sets was statistically significant (overall OR 0.76; 95% CI: 0.60 to 0.96, P = 0.02). Low levels of heterogeneity were found in most meta-analyses of MCL and qualitative ovarian reserve biomarkers, while heterogeneity was high in meta-analyses performed for quantitative measures. WIDER IMPLICATIONS: MCL in regularly cycling women is closely related to ovarian reserve biomarkers during the reproductive years. A short MCL, as compared to normal, is significantly associated with lower ORT values, reduced fecundability and inferior IVF outcomes, independent of age. The results imply that short MCL may be a sign of ovarian aging, combining the quantitative and qualitative facets of ovarian reserve. Educational efforts ought to be designed to guide women with short MCL at a young age, who desire children in the future, to seek professional counselling.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Entities:  

Keywords:  IVF; anti-Müllerian hormone; antral follicle count; fecundability; menstrual cycle length; ovarian reserve biomarkers; ovarian reserve tests

Mesh:

Substances:

Year:  2020        PMID: 32514566     DOI: 10.1093/humupd/dmaa013

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  5 in total

1.  Folate intake and ovarian reserve among women attending a fertility center.

Authors:  Mumta Kadir; Robert B Hood; Lidia Mínguez-Alarcón; Ana Belén Maldonado-Cárceles; Jennifer B Ford; Irene Souter; Jorge E Chavarro; Audrey J Gaskins
Journal:  Fertil Steril       Date:  2021-11-19       Impact factor: 7.329

2.  Relationship Between Anti-Müllerian Hormone and In Vitro Fertilization-Embryo Transfer in Clinical Pregnancy.

Authors:  Xing Yu Sun; Yun Zhu Lan; Shuang Liu; Xiao Ping Long; Xi Guang Mao; Ling Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-04       Impact factor: 5.555

3.  Clinical Efficacy of Assisted Reproductive Technology Combined with Progesterone Capsules in the Treatment of Infertility Caused by Diminished Ovarian Reserve and Its Influence on Serum FSH, E2, and LH Levels of Patients.

Authors:  Lingqin Chen; Mindong Lai; Xiaojin Huang; Fang Zeng; Wei Xia; Qingping Yang; Sisun Liu
Journal:  J Healthc Eng       Date:  2022-03-24       Impact factor: 2.682

4.  Association Between the Ratio of Ovarian Stimulation Duration to Original Follicular Phase Length and In Vitro Fertilization Outcomes: A Novel Index to Optimise Clinical Trigger Time.

Authors:  Xinyang Zhao; Xu Zhang; Shanshan Wu; Jichun Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

5.  Oligo/Amenorrhea Is an Independent Risk Factor Associated With Low Ovarian Response.

Authors:  Kai-Lun Hu; Kwanghann Gan; Yue Ying; Junyan Zheng; Ruixue Chen; Jinglei Xue; Yiqing Wu; Yifeng Liu; Yimin Zhu; Lanfeng Xing; Dan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.